Aberrant activation of MLL by chromosomal translocations or inactivation of PRC2 subunits by loss-of-function mutations or silencing are conducive to AML onset and these genetic lesions are frequently accompanied by the upregulation of HOXA9 expression [17]. This evidence concerns the gene HOXA9 and acute myeloid leukemia.